Prime Capital Investment Advisors »

Rani Therapeutics Hldgs shares owned by Prime Capital Investment Advisors

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Prime Capital Investment Advisors from 13F filings

Historical chart of Prime Capital Investment Advisors investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Prime Capital Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Prime Capital Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $55k 17k 3.32
2023-09-30 $36k 17k 2.18
2023-06-30 $69k 17k 4.12
2022-12-31 $198k 34k 5.90

More positions owned by Prime Capital Investment Advisors

Vanguard Index Fds Total Stk Mkt Etf (VTI)
Invesco Qqq Tr Unit Ser 1 Etf (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Etf (SPY)
Ishares Tr Us Treas Bd Etf Etf (GOVT)
Apple Stock (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf Etf (SCHX)
Vanguard Index Fds S&p 500 Etf Etf (VOO)
Ishares Tr Core Us Aggbd Et Etf (AGG)
Microsoft Corp Stock (MSFT)
Ishares Tr Core S&p Ttl Stk Etf (ITOT)
Schwab Strategic Tr Intl Eqty Etf Etf (SCHF)
Schwab Strategic Tr Us Mid-cap Etf Etf (SCHM)
Vanguard Index Fds Value Etf Etf (VTV)
Ishares Tr Sp Smcp600vl Etf Etf (IJS)
Vanguard Mun Bd Fds Tax Exempt Bd Etf (VTEB)

View all positions for Prime Capital Investment Advisors

Top funds holding Rani Therapeutics Hldgs

Vanguard Group
United Services Automobile Association
Alphabet
Stifel Financial
Geode Capital Management
Bank of America Corporation
BlackRock
Marc Lasry
Luther King Capital Management Corporation
Bridgeway Capital Management
Mot
Brown Advisory Holdings Incorporated
Alpha Square Group S
Citadel Advisors
XR Securities

View all funds holding Rani Therapeutics Hldgs